A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.
Clinical trial NCT06862531 · COMPLETED
Trial details
- NCT number
- NCT06862531
- Sponsor
- Bioaster
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2020-11-17
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.